{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:03:58Z","timestamp":1770455038265,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.90033","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T03:30:14Z","timestamp":1755142214000},"source":"Crossref","is-referenced-by-count":0,"title":["Unusual Chronotropic Incompetence in a Young Patient: Mitigating the Fear of Fatal Bradyarrhythmia When Antipsychotics Are Deemed Necessary"],"prefix":"10.7759","author":[{"given":"Prutha V","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yash K","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minaal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid A","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M","family":"Exeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul P","family":"Osmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Sulliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partam","family":"Manalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X16666200721154143","article-title":"Evaluation and management of asymptomatic bradyarrhythmias","volume":"17","author":"\u00c7inier G","year":"2021","unstructured":"\u00c7inier G, Haseeb S, Bazoukis G, Yeung C, G\u00fcl EE. Evaluation and management of asymptomatic bradyarrhythmias. Curr Cardiol Rev. 2021, 17:60-7. 10.2174\/1573403X16666200721154143","journal-title":"Curr Cardiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0687","article-title":"QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes","volume":"108","author":"Wenzel-Seifert K","year":"2011","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int. 2011, 108:687-93. 10.3238\/arztebl.2011.0687","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach SR","year":"2013","unstructured":"Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013, 54:1-13. 10.1016\/j.psym.2012.11.001","journal-title":"Psychosomatics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24093","article-title":"Comparison of methods for correcting QT interval in athletes and young people: a systematic review","volume":"46","author":"Mahendran S","year":"2023","unstructured":"Mahendran S, Gupta I, Davis J, Davis AJ, Orchard JW, Orchard JJ. Comparison of methods for correcting QT interval in athletes and young people: a systematic review. Clin Cardiol. 2023, 46:1106-15. 10.1002\/clc.24093","journal-title":"Clin Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110376685","article-title":"Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis","volume":"25","author":"Chung AK","year":"2011","unstructured":"Chung AK, Chua SE. Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis. J Psychopharmacol. 2011, 25:646-66. 10.1177\/0269881110376685","journal-title":"J Psychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221097261","article-title":"Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis","volume":"12","author":"Huhn M","year":"2022","unstructured":"Huhn M, Arndt T, Schneider-Thoma J, Leucht S. Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis. Ther Adv Psychopharmacol. 2022, 12:10.1177\/20451253221097261","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12524","article-title":"Electrocardiographic characteristics in individuals with cocaine use disorder","volume":"26","author":"Mahoney JJ 3rd","year":"2017","unstructured":"Mahoney JJ 3rd, Haile CN, De La Garza R 2nd, Thakkar H, Newton TF. Electrocardiographic characteristics in individuals with cocaine use disorder. Am J Addict. 2017, 26:221-7. 10.1111\/ajad.12524","journal-title":"Am J Addict"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37524","article-title":"Chronic cocaine abuse as a cause of sinus bradycardia","volume":"15","author":"Mousa A","year":"2023","unstructured":"Mousa A, Rashid MH, Bukhari SN, Abu-Abaa M, Pahuja KH. Chronic cocaine abuse as a cause of sinus bradycardia. Cureus. 2023, 15:e37524. 10.7759\/cureus.37524","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/08964289.2014.897931","article-title":"Bradycardia as a marker of chronic cocaine use: a novel cardiovascular finding","volume":"42","author":"Sharma J","year":"2016","unstructured":"Sharma J, Rathnayaka N, Green C, Moeller FG, Schmitz JM, Shoham D, Dougherty AH. Bradycardia as a marker of chronic cocaine use: a novel cardiovascular finding. Behav Med. 2016, 42:1-8. 10.1080\/08964289.2014.897931","journal-title":"Behav Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden DM","year":"2004","unstructured":"Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004, 350:1013-22. 10.1056\/NEJMra032426","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010376973","article-title":"Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics","volume":"51","author":"Pollak PT","year":"2011","unstructured":"Pollak PT, Verjee ZH, Lyon AW. Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics. J Clin Pharmacol. 2011, 51:1112-5. 10.1177\/0091270010376973","journal-title":"J Clin Pharmacol"},{"key":"ref12","article-title":"Quetiapine","author":"Maan JS","year":"2025","unstructured":"Maan JS, Ershadi M, Khan I, Saadabadi A. Quetiapine. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0461-9","article-title":"Cardiovascular disease in clozapine-treated patients: evidence, mechanisms, and management","volume":"31","author":"Ronaldson KJ","year":"2017","unstructured":"Ronaldson KJ. Cardiovascular disease in clozapine-treated patients: evidence, mechanisms, and management. CNS Drugs. 2017, 31:777-95. 10.1007\/s40263-017-0461-9","journal-title":"CNS Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2011.03.019","article-title":"Single-dose ziprasidone associated with QT interval prolongation","volume":"30","author":"Witsil JC","year":"2012","unstructured":"Witsil JC, Zell-Kanter M, Mycyk MB. Single-dose ziprasidone associated with QT interval prolongation. Am J Emerg Med. 2012, 30:837.e1-2. 10.1016\/j.ajem.2011.03.019","journal-title":"Am J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht S","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, et al.. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013, 382:951-62. 10.1016\/S0140-6736(13)60733-3","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00888-6","article-title":"Torsades de pointes associated with intravenous haloperidol in critically ill patients","volume":"81","author":"Sharma ND","year":"1998","unstructured":"Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol. 1998, 81:238-40. 10.1016\/s0002-9149(97)00888-6","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122012896","article-title":"The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of torsades de pointes","volume":"41","author":"Tisdale JE","year":"2001","unstructured":"Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of torsades de pointes. J Clin Pharmacol. 2001, 41:1310-8. 10.1177\/00912700122012896","journal-title":"J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.03.003","article-title":"Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder","volume":"32","author":"Miceli JJ","year":"2010","unstructured":"Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano RJ, O'Gorman C, Harrigan RH. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. Clin Ther. 2010, 32:472-91. 10.1016\/j.clinthera.2010.03.003","journal-title":"Clin Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9406813","article-title":"Two sudden and unexpected deaths of patients with schizophrenia associated with intramuscular injections of antipsychotics and practice guidelines to limit the use of high doses of intramuscular antipsychotics","volume":"2016","author":"Wahidi N","year":"2016","unstructured":"Wahidi N, Johnson KM, Brenzel A, de Leon J. Two sudden and unexpected deaths of patients with schizophrenia associated with intramuscular injections of antipsychotics and practice guidelines to limit the use of high doses of intramuscular antipsychotics. Case Rep Psychiatry. 2016, 2016:9406813. 10.1155\/2016\/9406813","journal-title":"Case Rep Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v05n0504","article-title":"New generation antipsychotic drugs and QTc interval prolongation","volume":"5","author":"Vieweg WV","year":"2003","unstructured":"Vieweg WV. New generation antipsychotic drugs and QTc interval prolongation. Prim Care Companion J Clin Psychiatry. 2003, 5:205-15. 10.4088\/pcc.v05n0504","journal-title":"Prim Care Companion J Clin Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338904-unusual-chronotropic-incompetence-in-a-young-patient-mitigating-the-fear-of-fatal-bradyarrhythmia-when-antipsychotics-are-deemed-necessary","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T03:30:16Z","timestamp":1755142216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338904-unusual-chronotropic-incompetence-in-a-young-patient-mitigating-the-fear-of-fatal-bradyarrhythmia-when-antipsychotics-are-deemed-necessary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.90033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}